UniProtKB/SwissProt variant VAR

Variant information

Variant position:

1058

The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:

LB/B

The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Arginine (R) to Glutamine (Q) at position 1058 (R1058Q, p.Arg1058Gln).

Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:

Change from large size and basic (R) to medium size and polar (Q)

The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:

1

The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page

Other resources:

Links to websites of interest for the variant.

Variant rs41410450 [ dbSNP | Ensembl ]

Sequence information

Variant position:

1058

The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:

1531

The length of the canonical sequence.

Location on the sequence:

SIGGILASRCLHVDLLHSIL R SPMSFFERTPSGNLVNRFSK

The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	1 – 1531	Multidrug resistance-associated protein 1
Topological domain	1047 – 1089	Cytoplasmic
Domain	975 – 1256	ABC transmembrane type-1 2
Mutagenesis	1046 – 1046	R -> D. Slightly impairs leukotriene C4 and estradiol glucuronide transport.

Literature citations

Polymorphism of the ABC transporter genes, MDR1, MRP1 and MRP2/cMOAT, in healthy Japanese subjects.
Ito S.; Ieiri I.; Tanabe M.; Suzuki A.; Higuchi S.; Otsubo K.;
Pharmacogenetics 11:175-184(2001)
Cited for: VARIANTS SER-43; ILE-73; GLN-723 AND GLN-1058;

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot P33527: Variant p.Arg1058Gln